| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 03/06/2002 | CN1339063A Human hybrid host cell for mammalian gene expression |
| 03/06/2002 | CN1080256C Beta-lactams, methods for preparation of taxanes and sidechain-bearing taxanes |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6352729 Administering melothria plant extract to subjects having sepsis; preventing cytokine release |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | US20020026046 Mixing composition with reducing agent, heating; wherein any ribonucleases in composition are substantially inactivated or inhibited |
| 02/28/2002 | US20020025528 Use of genetic markers to diagnose familial dysautonomia |
| 02/26/2002 | US6350887 Chemical intermediates for anticarcinogenic agents |
| 02/26/2002 | US6350886 Anticarcinogenic agents |
| 02/26/2002 | US6350592 Aortic-specific enhancer sequence and uses thereof |
| 02/21/2002 | WO2001062899A3 Method of making embryoid bodies from primate embryonic stem cells |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/13/2002 | EP1179187A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
| 02/07/2002 | WO2002010343A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae |
| 02/07/2002 | WO2001055329A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | US20020015038 System and method for evaluating pockets in protein |
| 02/07/2002 | CA2417482A1 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae |
| 01/31/2002 | WO2001062801A3 Humanized antibodies that sequester amyloid beta peptide |
| 01/24/2002 | WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | WO2001055305A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/17/2002 | WO2002004597A2 Method and apparatus for synthesis of arrays of dna probes |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/08/2002 | CA2163636C Process for the sterilization of biological compositions and the product produced thereby |
| 01/08/2002 | CA2118113C Oil-body proteins as carriers of high-value peptides in plants |
| 01/03/2002 | WO2002000842A2 Methods for isolating centromere dna |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/02/2002 | EP1165616A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 01/02/2002 | CN1329663A Materials and methods for modification of plant lignin content |
| 12/27/2001 | WO2001098457A2 Surface model of a protein |
| 12/27/2001 | CA2410519A1 System and method for evaluating pockets in protein |
| 12/25/2001 | US6333403 Nucleotide sequences coding polypeptide associated with tumors; for use in diagnosis and treatment of tumors |
| 12/25/2001 | US6333174 Transforming a bacterial inoculant with a replicable plasmid having a double stranded dna, a tryptophan promoter, ribosome binding site, a translation start signal with structural genes coding a leade, culture with tryptophan |
| 12/20/2001 | WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 12/20/2001 | WO2001055306A3 Nucleic acids, proteins, and antibodies |
| 12/19/2001 | CN1076356C Protein having TPO activity |
| 12/18/2001 | CA2201762C Method for purifying keratinocyte growth factors |
| 12/13/2001 | WO2001094550A2 Identification and use of molecular markers indicating cellular reprogramming |
| 12/13/2001 | WO2001094546A2 Primer extension using a mixture of labelled and unlabelled nucleotides |
| 12/13/2001 | CA2416868A1 Identification and use of molecular markers indicating cellular reprogramming |
| 12/12/2001 | EP1162264A2 Chimeric hormone receptor |
| 12/11/2001 | CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 12/06/2001 | WO2001092487A2 Modified xylanases exhibiting increased thermophilicity and alkalophilicity |
| 12/06/2001 | WO2001092463A2 Method of rna cleavage |
| 12/05/2001 | EP0763114B1 Hepatitis g virus and molecular cloning thereof |
| 12/04/2001 | US6326171 Hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same |
| 11/29/2001 | WO2001090311A1 Novel probiotics for pet food applications |
| 11/29/2001 | WO2001090304A2 Nucleic acids, proteins, and antibodies |
| 11/29/2001 | US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 11/28/2001 | EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 11/27/2001 | US6322988 Providing sample of polynucleotide and selecting a region potentially containing variation; subjecting to template producing amplification reaction to produce double stranded polynucleotide templates; producing labelled fragments |
| 11/21/2001 | CN1075078C Producing process of stem cell factor |
| 11/15/2001 | WO2001085915A2 Identifying clusters of transcription factor binding sites |
| 11/15/2001 | WO2001085913A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 11/15/2001 | WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 11/15/2001 | CA2408268A1 Identifying clusters of transcription factor binding sites |
| 11/14/2001 | EP1066380B1 Soluble t cell receptor |
| 11/14/2001 | EP0576471B1 Recombinant virus vectors encoding human papillomavirus proteins |
| 11/08/2001 | WO2001083691A2 System for identifying and analyzing expression of are-containing genes |
| 11/07/2001 | EP1151132A2 Methods and reagents for inactivating ribonucleases |
| 11/07/2001 | EP1151109A1 Fucosyl transferase gene |
| 11/07/2001 | CN1074422C Method for preparing HCV epitope-contg. separated polypeptide |
| 11/07/2001 | CN1074255C Spray-drying process |
| 11/01/2001 | WO2001081582A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 11/01/2001 | WO2001081542A2 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data |
| 11/01/2001 | US20010036456 Administering Protein C |
| 11/01/2001 | CA2407523A1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 10/30/2001 | US6310201 (3r-cis)-1-benzoyl-3-(1-methoxy-1-methylethoxy)-4-phenyl-2-aze tidinone. |
| 10/25/2001 | WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 10/24/2001 | CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway |
| 10/23/2001 | US6306652 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 10/17/2001 | EP1144454A2 Modified peptides as therapeutic agents |
| 10/16/2001 | CA2044626C Type a platelet-derived growth factor receptor gene |
| 10/11/2001 | WO2001075164A2 Rna sequence-specific mediators of rna interference |
| 10/11/2001 | CA2404890A1 Rna sequence-specific mediators of rna interference |
| 10/10/2001 | EP1141308A2 Group b streptococcus proteins, and their use |
| 10/10/2001 | CN1317045A Pharmaceutical uses of NAB1 and NAB2 |
| 10/09/2001 | US6300475 Interferon PRO655 |
| 10/04/2001 | EP1137768A1 Human hybrid host cell for mammalian gene expression |
| 10/03/2001 | CN1315996A Enzyme stabilization by cationic surfactants |
| 09/27/2001 | US20010024824 Stem cells and their use in transplantation |
| 09/27/2001 | US20010024818 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 09/26/2001 | CN1071791C DNA molecule for coding BSSL/CEL |
| 09/20/2001 | WO2001068710A1 Monoclonal antibodies to the human ldl receptor, their production and use |
| 09/19/2001 | EP1133559A2 Human orphan g protein-coupled receptors |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |
| 09/18/2001 | CA2149236C Novel xylanase, process for producing the same, method for the treatment of pulp, and production of xylo-oligosaccharides |
| 09/18/2001 | CA1341292C The manufacture and expression of consensus human leukocyte interferon |
| 09/13/2001 | WO2001066697A2 Serum free cultivation of primate embryonic stem cells |
| 09/13/2001 | WO2001066573A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 09/12/2001 | CN1312859A Method for determining polynucleotide sequence variations |
| 09/07/2001 | WO2001055329A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055306A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055305A8 Nucleic acids, proteins, and antibodies |
| 09/05/2001 | CN1311818A Neurotrophic factors |